Intrahepatic total HBV DNA (it-HBV DNA) level might reflect the size of virus reservoir and correlate with the histological status of the liver. To quantitate it-HBV DNA in a series of 70 liver biopsies obtained from hepatitis B chronic patients, a modified version of the COBAS®Ampliprep/COBAS®TaqMan HBV test v2.0 was used for this purpose. The linearity and reproducibility of the modified protocol was tested by quantifying serial dilutions of a full-length HBV containing plasmid and it-HBV DNA from a reference patient. A good linear trend between the expected values and those generated by the assay was observed at different concentrations of both plasmid and reference patient (R 2 = 0.994 and 0.962, respectively). Differences between the values obtained in two independent runs were ≤0.3 log IU for the plasmid and ≤0.6 log IU/mg for the reference patient, showing a high inter-run reproducibility. In the 70 liver biopsies, it-HBV DNA level ranged from 1.4 to 5.4 log IU/mg, with a good linearity and reproducibility between the values obtained in two runs [R 2 = 0.981; median (IQR) difference of it-HBV DNA 0.05 (0.02–0.09) IU/mg]. The modified COBAS®Ampliprep/COBAS®TaqMan HBV test v2.0 allows an accurate quantitation of it-HBV DNA. Its determination may have prognostic value and may be a useful tool for the new therapeutic strategies aimed at eradicating the HBV infection.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Barnes E (2015) Therapeutic vaccines in HBV: lessons from HCV. Med Microbiol Immunol 204:79–86
Bayram A, Erkilic S, Ozkur A, Bayram M, Sari I (2008) Quantification of intrahepatic total hepatitis B virus DNA in chronic hepatitis B patients and its relationship with liver histology. J Clin Pathol 2008(61):338–342
Bianco C, Dodd RY (2013) Infectivity of occult hepatitis B from two different points of view. Transfusion 2013(53):1379–1381
Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P (2001) Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely “occult”? Hepatology 34:194–203
Boyd A, Lacombe K, Lavocat F, Maylin S, Miailhes P, Lascoux-Combe C et al (2016) Decay of ccc-DNA marks persistence of intrahepatic viral DNA synthesis under tenofovir in HIV-HBV co-infected patients. J Hepatol 65:683–691
Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Villari D, de Franchis R et al (2000) Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Hepatology 31:507–512
De Mitri MS, Cassini R, Bernardi M (2010) Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections. Eur J Cancer 46:2178–2186
Han JH, Kim DG, Na GH, Kim EY, Lee SH, Hong TH et al (2015) De novo hepatitis B virus infection developing after liver transplantation using a graft positive for hepatitis B core antibody. Ann Surg Treat Res 89:145–150
Hussain M, Soldevila-Pico C, Emre S, Luketic V, Lok AS et al (2007) Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation. Liver Transpl 13:1137–1144
Lucifora J, Xia Y, Reisinger F, Zhang K, Stadler D, Cheng X et al (2014) Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA. Science 343:1221–1228
Raimondo G, Pollicino T, Romano L, Zanetti AR (2010) A 2010 update on occult hepatitis B infection. Pathol Biol 58:254–257
Thompson AJ, Nguyen T, Iser D, Ayres A, Jackson K, Littlejohn M et al (2010) Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 51:1933–1944
Yeh CT, So M, Ng J, Yang HW, Chang ML, Lai MW et al (2010) Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma. Hepatology 52:1922–1933
Yuen MF, Wong DK, Fung J, Ip P, But D, Hung I et al (2008) HBsAg Seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma. Gastroenterology 135:1192–1199
Wang Q, Fiel MI, Luan W, Blank S, Kadri H, Kim KW et al (2013) Impact of intrahepatic hepatitis B DNA and covalently closed circular DNA on survival after hepatectomy in HBV-associated hepatocellular carcinoma patients. Ann Surg Oncol 20:3761–3770
Wong DK, Yuen MF, Tse E, Yuan H, Sum SS, Hui CK et al (2004) Detection of intrahepatic hepatitis B virus DNA and correlation with hepatic necroinflammation and fibrosis. J Clin Microbiol 42:3920–3924
Wong DK, Fung J, Lee CK, Seto WK, Leung J, Huang FY et al (2016) Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection. Clin Microbiol Infect 22:290.e1–290.e3
Valentina Svicher and Marco Ciotti last joint last authorship.
About this article
Cite this article
Salpini, R., Piermatteo, L., Gill, U. et al. Quantification of intrahepatic total HBV DNA in liver biopsies of HBV-infected patients by a modified version of COBAS® Ampliprep/COBAS®TaqMan HBV test v2.0. Med Microbiol Immunol 206, 295–299 (2017). https://doi.org/10.1007/s00430-017-0504-3
- COBAS® TaqMan HBV test, v2.0
- Intrahepatic HBV DNA
- HBV DNA level
- HBV reservoir